title: Reply to Ruiz-Argüello et al.: Comparison study of two commercially available methods for the determination of infliximab, adalimumab, etanercept and anti-drug antibody levels.
authors: Theo
authors: T
authors: Rispens
authors: Desiree
authors: D
authors: van der Kleij
mesh_terms: D000068879:Adalimumab; D000906:Antibodies / Q000097:blood* / Q000276:immunology*; D000911:Antibodies, Monoclonal / Q000097:blood*; D061067:Antibodies, Monoclonal, Humanized / Q000097:blood*; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood*; D000069285:Infliximab; D018124:Receptors, Tumor Necrosis Factor / Q000097:blood*
chemical_list: D000906:Antibodies; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000069285:Infliximab; D000068879:Adalimumab; D000068800:Etanercept